CD59 and posterior cortical atrophy: For example: AMBP for PCa diagnosis [40], CD59 associated with PCa progression [41–43], CLU as a therapeutic target against PCa [44] and predictor for PCA recurrence [45], and PTGDS was found in increased concentration in urine from PCa patients [40].